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OBJECTIVES The study sought to determine the outcome of pregnancy in women with coarctation of the
thoracic aorta.
BACKGROUND Patients with coarctation of the thoracic aorta are expected to reach childbearing age, but data
on the outcome of pregnancy in this population are limited.
METHODS The Mayo Clinic database was reviewed for women of childbearing age (16 years old) with
a diagnosis of aortic coarctation evaluated from 1980 to 2000. Spectrum of cardiovascular
disease, surgical history, and obstetrical and neonatal outcomes were determined.
RESULTS Fifty women with coarctation had pregnancies: 30 had coarctation repair before pregnancy,
10 had repair after pregnancy, 4 had repair both before and after pregnancy, and 6 had no
history of repair. The 50 women had 118 pregnancies resulting in 106 births. There were 11
miscarriages (9%), 4 premature deliveries (3%), and 1 early neonatal death; 38 deliveries (36%)
were by cesarean section. Of the 109 offspring, 4 (4%) had congenital heart disease. A patient
with Turner syndrome died of a Stanford type A dissection at 36 weeks of pregnancy.
Nineteen women (38%) were known to have hemodynamically significant coarctation during
pregnancy (gradient 20 mm Hg). Fifteen women (30%) had hypertension during their
pregnancy, 11 of whom (73%) had hemodynamically significant coarctation during that time
(8 with native and 3 with residual/recurrent coarctation).
CONCLUSIONS Major cardiovascular complications were infrequent but continue to be a source of concern for
patients with coarctation who become pregnant. Systemic hypertension during pregnancy was
common and related to the presence of a significant coarctation gradient. (J Am Coll Cardiol
2001;38:1728–33) © 2001 by the American College of Cardiology
Coarctation of the thoracic aorta occurs in approximately
6% to 8% of patients with congenital heart disease (CHD)
(1). Although there may be some anatomical variation,
coarctation usually is characterized by a discrete narrowing
of the aorta distal to the left subclavian artery. The diagnosis
is made during infancy or childhood in 80% of patients, and
survival into adulthood is common (2). Females who have
aortic coarctation are expected to reach childbearing age
with a previous history of surgical repair or, less commonly,
with native coarctation (hemodynamically mild or unrecog-
nized). The outcome of pregnancy in women with coarcta-
tion of the aorta has been described in previous series and
case reports (3–15); however, the number of patients in
these reports has been small and the findings have been
contradictory. We sought to better define the maternal and
fetal outcomes of pregnancy in women with coarctation of
the thoracic aorta.
METHODS
The medical and surgical databases of the Mayo Clinic were
reviewed for all women with a diagnosis of aortic coarcta-
tion who were evaluated from 1980 to 2000 and who would
have been 16 years or older at the time of the study (2000).
Patients or relatives were contacted by mail or telephone,
and their medical records were reviewed. A detailed obstet-
rical history was obtained from each patient, with emphasis
on pregnancy, delivery, and fetal outcome (Table 1). Data
relating to the nature of the aortic coarctation, including the
type of surgical repair and the need for reoperation, were
collected. In addition, the status of the aortic valve, age at
surgery, and the presence of associated lesions were also
sought.
Hypertension was defined as present if reported by the
patient. Status of the coarctation during pregnancy was
determined when possible (native, surgically repaired with
or without residual/recurrent gradient). Coarctation seg-
ments with the presence of collaterals or a gradient of
20 mm Hg or greater (derived by catheterization, echocar-
diography, or arm-leg blood pressure difference, depending
on available data) were considered hemodynamically signif-
icant. The diagnosis of coarctation of the aorta was estab-
lished by one or more of the following: echocardiography,
computerized tomography, magnetic resonance imaging, or
cardiac catheterization with aortic root angiography or at
the time of surgical intervention. Patients with single
ventricle physiology, abdominal aortic coarctation, or
pseudocoarctation or those who died at an age 16 years
were excluded. In all offspring with CHD, the diagnosis was
made by a pediatric cardiologist. The protocol was reviewed
and approved by the Institutional Review Board of Mayo
Foundation.
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Statistical methods. The median and range were deter-
mined for continuous variables and frequencies for categor-
ical variables. Continuous variables were compared by the
Mann-Whitney U test. These included age at initial repair
for women with or without re-do surgery, age at initial
repair for women with or without persistent/late hyperten-
sion, age at initial repair for women with or without
hypertension during pregnancy, and infant weight in the
native coarctation or surgical repair group. Categorical
variables were compared by the Fisher exact test. These
included: 1) hypertension during pregnancy versus the
presence of coarctation, and 2) incidence of miscarriage,
cesarean delivery, and hypertension during pregnancy versus
the presence or absence of a previous repair. Ninety-five
percent confidence intervals (CIs) were derived for obstet-
rical and neonatal data. A p value 0.05 was considered
statistically significant. The SPSS 7.0 statistical software
package was used for all calculations.
RESULTS
One hundred thirty-seven potential subjects were identified
from the database review. After an initial chart review, 29
were excluded because of presence of single ventricle phys-
iology, abdominal coarctation, pseudocoarctation, or death
at an age 16 years. In the remaining 108 subjects,
questionnaires were sent and in those with no response
phone contact was attempted. Seventy-three subjects (68%)
were traced and agreed to respond. Of this group, 23 had
not been pregnant. At the time of the questionnaire, one
woman was pregnant for the first time and was excluded
from the study. One woman who died during pregnancy
and whose medical records were available was also included
in the data set. Fifty women had a history of pregnancy with
an established outcome: 30 became pregnant after surgical
repair of the coarctation, 10 were pregnant before surgical
repair, 4 had surgical repair both before and after pregnancy,
and 6 had no history of surgical repair (Fig. 1). The 50
women had a total of 118 pregnancies: 74 pregnancies
(63%) occurred in women who had previously had surgical
repair and 44 (37%) occurred in women with no previous
history of repair.
Spectrum of cardiovascular disease. Of the 50 women, 9
(18%) had associated cardiovascular lesions at birth in
addition to aortic coarctation: 4 had a history of patent
ductus arteriosus, 1 had a history of ventricular septal defect
(VSD), 1 had a history of both patent ductus arteriosus and
VSD, 2 had congenital aortic stenosis, and 1 had an
aberrant left subclavian artery distal to the coarctation
segment in the setting of a right-sided arch (Table 2).
Except for the latter patient and a patient with a small VSD,
all had had surgical repair of these associated anomalies
before becoming pregnant. The morphology of the aortic
valve was not known for 1 of the 50 women, but of the other
49, a total of 28 (57%) had a bicuspid aortic valve. After
having completed their pregnancies, five women eventually
required aortic valve replacement for stenosis. The median
time from the last pregnancy to the time of aortic valve
replacement was 25 years (range, 3 to 40 years). No women
had a history of hemodynamically significant aortic valve
insufficiency, and none had a mitral valve anomaly. None of
the women were known to have an aneurysmal dilation of
the ascending aorta during pregnancy. One patient had
Turner syndrome, and another had Noonan syndrome.
History of surgical intervention. Forty-four women
(88%) had a history of surgical intervention to repair the
aortic coarctation (Table 2). None had a history of percu-
taneous catheter-based intervention. The median age at the
time of the initial repair for the entire group was 15 years
(range, 1 to 60 years). The median age at the time of the
initial repair for the subgroup who had their first pregnancy
after repair was 13 years (range, 1 to 36 years). For this
subgroup, the median time from initial surgical repair to
first pregnancy was 13 years (range, 1 to 36 years). The type
of procedure at initial surgical repair varied: an end-to-end
anastomosis was performed in 15 women (34%), patch
aortoplasty in 13 (30%), interposition graft in 5 (11%), and
bypass graft in 1 (2%). No woman had subclavian flap
repair. For 10 women (23%), the type of procedure was not
known. Nine women (20%) had reoperation for recurrent
coarctation. The median age at initial repair for those who
had reoperation for residual or recurrent coarctation was 10
years (range, 1 to 19 years), compared with 17 years (range,
1 to 60 years) for those who did not have reoperation (p 
NS). Of the 44 women who had surgical repair, 26 (59%)
had persistent or late hypertension. For one woman, blood
Abbreviations and Acronyms
CHD  congenital heart disease
CI  confidence interval
NS  not significant
VSD  ventricular septal defect
Table 1. Data Abstracted From Questionnaire, Telephone
Interview and Medical Record Review
Cardiovascular data
Associated lesions
Bicuspid aortic valve
History of hypertension
Status of coarctation during pregnancy
Surgical history
Type of repair
Age at repair
Obstetrical history
Maternal age
Miscarriage
Type of delivery
Premature delivery
Hypertension
Preeclampsia
Neonatal data
Complication at birth
Birth weight
Congenital heart disease
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pressure level was not known. The median age at initial
repair in women with persistent or late hypertension was 21
years (range, 5 to 60 years), compared with 10 years (range,
1 to 36 years) for those without residual or late hypertension
(p  0.05).
Obstetrical and neonatal data. The 50 women had 118
pregnancies resulting in 106 live births. There were two
twin pregnancies and one triplet pregnancy. Nine women
had 11 miscarriages (9%), all of which occurred in the first
trimester of pregnancy. One woman had an ectopic preg-
nancy that was unsuccessful. No therapeutic abortion was
performed. One neonate died 2 h after delivery; no infor-
mation was available about the cause of death. Thirteen
women (26%) had been advised against becoming pregnant
because of perceived maternal and fetal risk. The median
maternal age at the time of pregnancy was 27 years (range,
17 to 39 years). The median number of pregnancies per
woman was two (range, 1 to 6). Of the 106 births, 38 (36%)
were cesarean deliveries, 7 of which were performed for
obstetrical reasons and the other 31 for perceived maternal
cardiovascular risk. Four women (3% of deliveries; 95% CI,
1% to 9%) had premature deliveries, defined as 37 weeks or
less of gestation: 3 were at 36 weeks of gestation and 1 twin
delivery occurred at 34 weeks. Two women (2% of deliver-
ies; 95% CI, 0% to 6%) had preeclampsia during pregnancy;
this occurred during their first pregnancy, and they had no
history of hypertension before or after pregnancy. In both
women, a significant gradient was present during pregnancy
(one with previous surgical repair had a residual gradient of
20 mm Hg, and the other had native coarctation and a
gradient of 49 mm Hg). Other pregnancy-related compli-
cations included one infant small for gestational age, one
pregnancy complicated by oligohydramnios, and two
women with gestational diabetes. The median infant weight
at delivery was 3.5 kg (range, 1.9 to 4.3 kg) (Table 3).
CHD in offspring. Four of 109 children (4%; 95% CI,
1–9%) were born with CHD. Two children were born with
CHD in the setting of a chromosomal abnormality or a
Figure 1. Study group characteristics.
Table 2. Spectrum of Disease in Pregnant Women With
History of Aortic Coarctation
Variable No. (%)
Associated lesions at birth (n  50) 9 18
PDA* 4
VSD 1
PDA and VSD 1
Congenital AS 2
Aberrant LSCA with right arch 1
Bicuspid aortic valve (n  49)† 28 57
History of surgical repair (n  50) 44 88
Initial surgical repair (n  44)‡
End-to-end anastomosis 15 34
Patch aortoplasty 13 30
Interposition graft 5 11
Bypass graft 1 2
Subclavian flap 0 0
Unknown 10 23
Reoperation for coarctation (n  44) 9 20
Percutaneous intervention (n  44) 0 0
History of residual or late hypertension (n  44)§ 26 59
Hypertension during pregnancy (n  50) 15 30
Coarctation during pregnancy (n  50) 19 38
*All patients underwent surgical division. †Morphology of the aortic valve was not
known for one woman. ‡Age at initial repair: median, 15 years (range, 1 to 60).
§History of hypertension was not established for one woman. Presence of hemody-
namically significant coarctation (defined as presence of collaterals or gradient
20 mm Hg).
AS  aortic stenosis; LSCA  left subclavian artery; PDA  patent ductus
arteriosus; VSD  ventricular septal defect.
Table 3. Obstetrical and Neonatal Data for 118 Pregnancies
Variable Value 95% CI*
Maternal age at pregnancy, years,
median (range)
27 (17–39)
No. of pregnancies,
median (range)
2 (1–6)
Miscarriage, no. (%) 11 (9) 5–16%
Cesarean delivery, no. (%) 38 (36) 24–42%
Premature delivery, no. (%) 4 (3) 1–9%
Preeclampsia, no. (%) 2 (2) 0–6%
Infant weight, kg, median (range) 3.5 (1.9–4.3)
Congenital cardiac defect in infant,
no. (%)
4 (4) 1–9%
*95% confidence intervals (CI) of percentages for categorical variables.
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recognized systemic syndrome. One mother had a child
with Down syndrome with complete atrioventricular canal.
A woman with Noonan syndrome bore a child with the
same syndrome and associated pulmonic stenosis. Two
children without a chromosomal abnormality or a recog-
nized systemic syndrome had cardiac congenital anomalies:
one with aortic coarctation requiring surgical repair and one
with a small VSD, which closed spontaneously.
Maternal outcome. One woman died of complications of a
Stanford type A dissection at 36 weeks of pregnancy (see
below). No other pregnancy-related maternal deaths or
serious cardiovascular complications occurred. There was no
documented case of endocarditis, congestive heart failure, or
intracranial hemorrhage. Excluding the 2 women who had
isolated preeclampsia during pregnancy, 15 women (30%;
95% CI, 18% to 45%) had systemic hypertension during
pregnancy. In many cases, it was difficult to determine
whether hypertension had been documented before the
pregnancy. Of this group of 15 women, 7 had native
coarctation that eventually was repaired, 3 required reop-
eration shortly after pregnancy, 1 had native coarctation that
never was repaired (gradient, 38 mm Hg), and 3 had had
surgical repair, with no significant residual coarctation
(gradient, 20 mm Hg). Detailed information was not
available for the one other woman. Thus, of the 15 women
with hypertension during pregnancy, 11 (73%) had hemo-
dynamically significant coarctation. Of the 19 women (38%
of the cohort) with hemodynamically significant coarctation
(native or residual/recurrent), 11 (58%) had hypertension
during pregnancy, compared with only 3 of the 27 women
(11%) with no hemodynamically significant coarctation
(p  0.001) (Table 4). For four women, the status of
coarctation during pregnancy was not known. The age at
coarctation repair did not influence the presence or absence
of hypertension during pregnancy (median, 11 years [range,
5 to 23 years] for those with hypertension vs. 13 years
[range, 1 to 36 years] for those without hypertension; p 
NS).
Patient with fatal aortic dissection during pregnancy. A
30-year-old woman with cytogenetically documented
Turner syndrome and a history of juxtaductal coarctation
had surgical repair with end-to-end anastomosis at age four
years. She also had a bicuspid aortic valve, with no hemo-
dynamically significant stenosis or regurgitation. The pa-
tient was receiving hormone replacement therapy with cyclic
estrogen and progesterone. In vitro egg fertilization from
her sister, followed by transcervical uterine embryo transfer,
resulted in a triplet pregnancy. At 12 weeks of pregnancy,
she had selective reduction to twin pregnancy. This woman
was not evaluated by a cardiologist at our institution.
Hypertension was not documented before or during preg-
nancy. She died suddenly at 36 weeks of pregnancy, and
emergency cesarean delivery was performed 25 min after
collapse. The twins were alive but ventilated and had seizure
activity. Autopsy of the woman demonstrated a Stanford
type A dissection with an entry tear in the proximal aorta,
with associated hemopericardium and tamponade. The
ascending aorta had cystic degeneration of the media. Only
mild recoarctation was reported at the previous repair site.
The maximal diameter of the ascending aorta was 2.9 cm.
Native coarctation versus repaired coarctation. The dif-
ferences in obstetrical, neonatal, and maternal outcomes
between women who had had surgical repair before preg-
nancy (the “postrepair group”) and those who did not (the
“native group”) were not statistically significant. The mis-
carriage rate was 8% for the postrepair group and 11% for
the native group (p  NS). The cesarean delivery rate was
40% among the postrepair group and 28% among the native
group (p  NS). The median infant weight was 3.3 kg
(range, 1.9 to 4.5 kg) for the postrepair group and 3.2 kg
(range, 1.8 to 4.3 kg) for the native group (p  NS). Of the
34 women in the postrepair group, 8 (24%) had hyperten-
sion during pregnancy, compared with 7 of the 16 women
(43%) in the native group (p  NS).
DISCUSSION
Several issues are of concern in the care of a woman with
coarctation of the aorta who becomes pregnant. Possible
changes in the aortic wall during the gravid state,
coarctation-associated aortopathy, and long-standing hy-
pertension combine to increase the risk of aortic rupture or
dissection. Theoretically, beta-adrenergic blockade may de-
crease the risk of these events by decreasing the hemody-
namic stress on the aortic wall, although this remains
unproved in pregnancy. Poorly controlled hypertension
leads to adverse neonatal (growth retardation, abruptio
placentae, and premature delivery) and maternal (renal
failure, hypertensive crisis) outcomes (16). In addition,
hypertensive surges may precipitate the rupture of an intra-
cranial aneurysm, which reportedly has an increased inci-
dence in this population (17). Some commonly used classes
of antihypertensive agents, such as angiotensin-converting
enzyme inhibitors, have teratogenic effects and must be
discontinued before conception. Significant stenosis at the
site of coarctation with a pressure drop distally may result in
placental hypoperfusion (5). Associated anomalies such as a
stenotic bicuspid aortic valve may become hemodynamically
significant and symptomatic with the physiologic changes of
pregnancy. Endarteritis or endocarditis is a source of con-
cern at the time of delivery. Also, compared with the general
population, the child of a mother with aortic coarctation is
Table 4. Contingency Table of Relation Between Hypertension
During Pregnancy and Presence of Coarctation*†
Hypertension No Hypertension
Coarctation present 11 8
Coarctation not present 3 24
*Includes native coarctation or residual/recurrent coarctation (defined as presence of
collaterals or gradient 20 mm Hg). †Four women were not included because of
insufficient data to determine status of coarctation at time of pregnancy. Of 19 women
with coarctation present, 11 (58%) had hypertension during pregnancy, compared
with 3 of 27 women (11%) without coarctation (p  0.001).
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at increased risk for CHD (18). The reported maternal (0%
to 9% mortality) and neonatal (8% to 19% spontaneous
abortion) outcomes vary widely among previously published
series (3–15), perhaps because the older reports predated
widespread access to surgical repair and modern advances in
cardiac diagnosis and obstetric care. Our report represents
the largest series of pregnant women with aortic coarctation.
Maternal outcome. The woman with Turner syndrome
had a catastrophic cardiovascular complication, dying of
aortic dissection at 36 weeks of pregnancy. Several cases
have been reported of aortic rupture or dissection during
pregnancy in women with aortic coarctation (4,19). An
intrinsic aortopathy associated with aortic coarctation has a
predisposition for dilation, rupture, and dissection (20–23).
Also, because of hormonal and hemodynamic alterations,
pregnancy appears to increase the likelihood of dissection.
In a report by Williams et al. (24), one-half of aortic
dissections in women younger than 40 years occurred during
pregnancy. The presence of a bicuspid aortic valve has also
been linked with aortopathy (25). Women with Turner
syndrome are at increased risk for aortic rupture or dissec-
tion, even if they do not have coarctation, bicuspid aortic
valve, or hypertension (26,27). Our patient had several risk
factors for dissection or rupture of the aorta, that is, Turner
syndrome, bicuspid aortic valve, previous coarctation, and
pregnancy. Although aortic dilation increases the risk of
rupture or dissection (28), the aortic dimension of our
patient with Turner syndrome was within normal limits.
Oocyte donation and embryo transfer technology have made
pregnancy possible in women with Turner syndrome (29).
These women will need to be evaluated carefully, counseled
about potential risks, and monitored closely for aortopathy
and aortic complications.
In our series, 37% of the pregnancies occurred in women
with native coarctation and 63% in women whose coarcta-
tion had been repaired (median age at initial repair, 13
years). Future series probably will report a higher proportion
of women who had surgical repair at an earlier age,
reflecting improvement in clinical practice. The role of
percutaneous intervention in coarctation is evolving (30); it
has been used primarily to repair recurrent coarctation.
Angioplasty, with or without stenting, increasingly is being
used to repair native coarctation. Theoretically, the localized
dissection at the time of inflation could predispose the site
to further dissection or rupture, especially during pregnancy.
To date, there have been no reports of women with aortic
coarctation who had percutaneous intervention before be-
coming pregnant.
Hypertension during pregnancy. Hypertension in preg-
nancy may be due to pre-existing systemic hypertension or
preeclampsia or it may be transient. The incidence of
systemic hypertension during pregnancy is 1% to 5% (16),
but in our series, 30% of the women (95% CI, 18% to 45%)
had systemic hypertension during pregnancy. The majority
of them (73%) had native coarctation with a hemodynam-
ically significant gradient or evidence of residual or recurrent
coarctation. Of the women who had hemodynamically
significant coarctation (native or residual/recurrent), 58%
had hypertension during pregnancy. However, only 11% of
the women without hemodynamically significant coarcta-
tion had hypertension during pregnancy. Earlier reports
have shown that pregnant women with coarctation have a
blood pressure response similar to that of normal patients
(4). The tendency is for blood pressure to decrease during
the middle trimester of pregnancy and then return to
pregestational levels at preterm. The presence of hyperten-
sion during pregnancy in our group most likely reflected
prepregnancy-elevated blood pressure. Our data suggest
that the degree of obstruction at the site of coarctation is
important independently of the state of repair. Although the
age at initial repair predicted the presence of residual or late
hypertension for the entire group, no significant relation
existed between the age at initial repair and hypertension
during pregnancy. This most likely was due to the small
number of patients in the study group.
Obstetrical and neonatal outcome. The rate of cesarean
delivery for the study group was 36% (95% CI, 24% to
42%), which is higher than the national rate of up to 21.8%
(31). This high rate probably was due to a perceived
cardiovascular risk for the mother from an increase in blood
pressure during delivery. Although vaginal delivery generally
is preferred for women with CHD, cesarean delivery may be
safer if the woman has significant systemic hypertension, a
dilated aorta, or significant residual coarctation.
The miscarriage rate in our series was 9% (95% CI, 5% to
16%), which is equivalent to the expected national rate of
10% (32). Also, 2% of the pregnancies (95% CI, 0% to 6%)
were complicated by preeclampsia, which is comparable to
the national rate of 3% (33). The incidence of CHD in the
offspring was 4% (95% CI, 1% to 9%), which is similar to
the previously reported rate in parents with congenital heart
disease (18).
General issues regarding pregnant women with aortic
coarctation. Pregnant women with aortic coarctation may
present in several ways. Most commonly they have a history
of previous surgical repair. Occasionally, coarctation is
diagnosed initially during pregnancy when a cause for
hypertension is sought (7) or when aortic dissection occurs
(19). Occasionally, a woman with an established mild native
coarctation may become pregnant. Except for our patient
with Turner syndrome and aortic dissection, the major
morbidity during pregnancy in our series—whether the
woman had had native coarctation or surgical repair—was
hypertension related to a hemodynamically significant gra-
dient at the site of coarctation.
Study limitations. In addition to the problems inherent
with any retrospective study, several limitations should be
emphasized. Many of the women identified were referred to
the Mayo Clinic specifically for surgical intervention, and
not all subjects responded to the questionnaire. These two
issues create potential selection bias and this may limit
generalization of the results of this study. Only a small
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proportion of the women received obstetrical care at the
Mayo Clinic, making it difficult to access the details of the
pregnancy. The exact status of aortic valve function during
pregnancy was available for only a limited number of
patients. Data on aortic size during pregnancy were not
available and would be important for proper counseling in
this population. The majority of offspring data were derived
from the questionnaire and were not confirmed by review of
outside material. Finally, we were not able to report on the
use or type of antihypertensive agents or blood pressure
control during pregnancy.
Conclusions. Most women with coarctation of the tho-
racic aorta reach childbearing age. Although major cardio-
vascular complications are infrequent in pregnant women
with coarctation, they continue to be a source of concern.
The obstetrical and neonatal outcomes of the women in our
series were similar to those of the general population, except
for a modest increase in the rate of cesarean delivery.
Systemic hypertension during pregnancy was common and
related to a hemodynamically significant coarctation gradi-
ent. Women with a history of coarctation of the aorta who
contemplate pregnancy should have a formal hemodynamic
assessment of the site of coarctation, preferably before
conception, and undergo close monitoring of blood pressure
during pregnancy.
Reprint requests and correspondence: Dr. Heidi M. Connolly,
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